Cleveland-based BIOHM Health, a microbiome company, has raised an undisclosed amount of funding. The investor was Vanterra Capital.
CLEVELAND, Dec. 19, 2017 /PRNewswire/ — BIOHM Health, a microbiome company guided by the cutting edge research of Dr. Mahmoud Ghannoum, is pleased to announce funding by New York based private equity firm Vanterra Capital. Vanterra’s strategic investment in BIOHM Health emphasizes the firm’s growing activity in the health & wellness sectors.
“Vanterra’s investment in BIOHM Health underscores consumer demand for truly innovative products in the microbiome and digestive health space,” stated BIOHM Health CEO Afif Ghannoum. “Vanterra has a keen understanding of the health & wellness market and BIOHM Health is on the forefront of applying cutting-edge microbiome research to consumer products. It’s a win-win partnership.” Vanterra will join the BIOHM Health board along with the founders. Terms of the investment were not disclosed.
Following 20 years of research supported by the National Institutes of Health (NIH), Dr. Ghannoum’s work lead to the critical discovery that bad bacteria and bad fungi work together to create digestive plaque (also known as digestive biofilm). Applying proprietary dual-action technology that neutralizes the bad bacteria and fungi, BIOHM is the first probiotic engineered to breakdown digestive plaque, while maintaining the balance of the gut’s total microbiome of bacteria and fungi.
In addition to probiotics and other gut health products, BIOHM Health offers The BIOHM Gut Report, which identifies and measures the gut’s important bacteria and fungi levels and provides individuals with actionable wellness recommendations, including nutritional advice based on personalized results.
BIOHM Health has processed and analyzed more gut microbiome samples than the NIH’s entire Human Microbiome Project.
ABOUT BIOHM HEALTH
BIOHM Health was founded by Afif Ghannoum and Dr. Mahmoud Ghannoum after his breakthrough discovery that bad bacteria and bad fungus work together to create digestive imbalance. Dr. Ghannoum realized that today’s probiotics and microbiome tests had not been engineered to address the gut’s total microbiome of bacteria and fungi, entirely ignoring the role fungi plays in digestive health. As a result, he created BIOHM Health: The first company that addresses the gut’s total microbiome of both bacteria and fungi.
BIOHM Health was founded to be the first total microbiome company. BIOHM’s mission is simple: to engineer elegant products and tests that address the total microbiome of both bacteria and fungi, allowing consumers to maintain total digestive health. For more information visit: www.BIOHMhealth.com.
ABOUT VANTERRA CAPITAL
Vanterra Capital is a global private equity firm that manages assets for a diverse investor base of ultra-high net worth partners and leading institutions. Vanterra seeks to establish strategic relationships with specialized operators that have a unique competitive advantage within specific industries or strategies. By partnering with specialized management teams to create premier investment platforms, Vanterra seeks to opportunistically deploy capital to support the strategic and financial objectives of rapidly growing companies. For more information visit: www.vanterra.com or contact firstname.lastname@example.org.